Assistant Professor, Ophthalmology, Oregon Health and Science University School of Medicine
Infectious Disease
Dr. Kevin L. Winthrop, MD
|
|
Give Review
Kevin Winthrop is an expert in the field of Infectious Disease. He went to medical school at Oregon Health & Science University School of Medicine. He has 1 awards "CMS Meaningful Use Stage 1 Certification". Kevin L. Winthrop is also a published physician. He has 75 paper published. The most recent paper is: Risk of Herpes Zoster in Auto-immune and Inflammatory diseases: Implications for Vaccination. Doctor Kevin L. Winthrop, MD accepts Medicare payments and is listed with Medicare.gov.
Publications
- Comparative Effectiveness of Antibiotic Prophylaxis in Cataract Surgery.
- Infection Risk and Safety of Corticosteroid Use.
- A Rhesus Macaque Model of Pulmonary Nontuberculous Mycobacterial Disease.
- The Challenge of Pulmonary Nontuberculous Mycobacterial Infection.
- Reply to: "Comment on 'Time to update guidelines on screening for latent tuberculosis infection in dermatologic patients being treated with tumor necrosis factor-alfa ...
- Nontuberculous mycobacteria infections in immunosuppressed hosts.
- Cryptococcus gattii infection in solid organ transplant recipients: description of Oregon outbreak cases.
- Population-Based Incidence of Pulmonary Nontuberculous Mycobacterial Disease in Oregon 2007-2012.
- Diagnosis and treatment for ocular tuberculosis among uveitis specialists: the international perspective.
- The tolerability of linezolid in the treatment of nontuberculous mycobacterial disease.
- Reply to Letter to the Editor: Differential risk of herpes zoster infection with biologic use in rheumatoid arthritis.
- Risks of Herpes Zoster in Patients with Rheumatoid Arthritis According to Biologic Disease Modifying Therapy.
- Vaccinations for rheumatoid arthritis.
- Lack of Consensus in the Diagnosis and Treatment for Ocular Tuberculosis among Uveitis Specialists.
- Herpes Zoster and Tofacitinib Therapy in Patients with Rheumatoid Arthritis.
- Risk of hospitalised infection in rheumatoid arthritis patients receiving biologics following a previous infection while on treatment with anti-TNF therapy.
- Risk of hospitalized bacterial infections associated with biologic treatment among U.S. Veterans with Rheumatoid Arthritis.
- Use of health plan combined with registry data to predict clinical trial recruitment.
- The geographic diversity of nontuberculous mycobacteria isolated from pulmonary samples: an NTM-NET collaborative study.
- Persistence of Staphylococcus aureus colonization among individuals with immune-mediated inflammatory diseases treated with TNF-α inhibitor therapy.
- Update on the safety profile of certolizumab pegol in rheumatoid arthritis: an integrated analysis from clinical trials.
- TNFs, TB, testing, and treatment: Teeing up the questions.
- Non-viral opportunistic infections in new users of tumour necrosis factor inhibitor therapy: results of the SAfety Assessment of Biologic ThERapy (SABER) Study.
- Bedfellows: mycobacteria and rheumatoid arthritis in the era of biologic therapy.
- Physician attitudes regarding school-located vaccination clinics.
- Association between the initiation of anti-tumor necrosis factor therapy and the risk of herpes zoster.
- Incidence of selected opportunistic infections among children with juvenile idiopathic arthritis.
- Mycobacterium chelonae Facial Infections Following Injection of Dermal Filler.
- Update on the epidemiology of pulmonary nontuberculous mycobacterial infections.
- Mycobacterial diseases and antitumour necrosis factor therapy in USA.
- Association between anti-TNF-? therapy and interstitial lung disease.
- Decreased postoperative endophthalmitis rate after institution of intracameral antibiotics in a Northern California eye department.
- Infections and biologic therapy in rheumatoid arthritis: our changing understanding of risk and prevention.
- You can't always get what you want, but if you try sometimes (with two tests--TST and IGRA--for tuberculosis) you get what you need.
- Initiation of anti-TNF therapy and the risk of optic neuritis: from the safety assessment of biologic ThERapy (SABER) Study.
- Patients with nontuberculous mycobacteria: comparison of updated and previous diagnostic criteria for lung disease.
- Association between vaccination for herpes zoster and risk of herpes zoster infection among older patients with selected immune-mediated diseases.
- Ocular toxoplasmosis II: clinical features, pathology and management.
- Photo Quiz. Happy buddha?
- Clinical spectrum of tuberculous optic neuropathy.
- Ocular toxoplasmosis I: parasitology, epidemiology and public health.
- Incidence and risk factors for Progressive Multifocal Leukoencephalopathy among patients with selected rheumatic diseases.
- Initiation of Tumor Necrosis Factor-? Antagonists and the Risk of Hospitalization for Infection in Patients With Autoimmune Diseases.
- Therapy: Off-label biologics use and infection risk-the great unknown.
- Study design for a comprehensive assessment of biologic safety using multiple healthcare data systems.
- Pulmonary disease associated with nontuberculous mycobacteria, Oregon, USA.
- Geographic Distribution of Endemic Fungal Infections among Older Persons, United States.
- Interferon-gamma release assays for diagnosis of latent tuberculosis infection: evidence in immune-mediated inflammatory disorders.
- Distinguishing tuberculosis from nontuberculous mycobacteria lung disease, Oregon, USA.
- Tuberculosis of the Nasolacrimal Duct.
- The reliability of diagnostic coding and laboratory data to identify tuberculosis and nontuberculous mycobacterial disease among rheumatoid arthritis patients using an...
- Pulmonary nontuberculous mycobacterial disease prevalence and clinical features: an emerging public health disease.
- The emergence of retinopathy of prematurity in guatemala.
- Update on rheumatic manifestations of infectious diseases.
- Nontuberculous mycobacterial disease prevalence and risk factors: a changing epidemiology.
- Nontuberculous mycobacteria infections and anti-tumor necrosis factor-alpha therapy.
- Preventing and treating biologic-associated opportunistic infections.
- Sequelae of World War II: an outbreak of chronic cutaneous nontuberculous mycobacterial infection among Satowanese islanders.
- Interferon-gamma release assays for diagnosing mycobacterium tuberculosis infection in renal dialysis patients.
- A novel assay for screening patients for latent tuberculosis infection prior to anti-TNF therapy.
- Mycobacterium marinum presenting as large verrucous plaques on the lower extremity of a South Pacific Islander.
- Nontuberuclous mycobacterial disease: updated diagnostic criteria for an under-recognized infectious complication of anti-tumor necrosis factor therapy.
- The reliability of anterior segment lesions as indicators of onchocercal eye disease in Guatemala.
- Risk and prevention of tuberculosis and other serious opportunistic infections associated with the inhibition of tumor necrosis factor.
- Influenza, Winter Olympiad, 2002.
- Tuberculosis associated with therapy against tumor necrosis factor alpha.
- Mycobacteria in nail salon whirlpool footbaths, California.
- Tuberculosis cases associated with infliximab and etanercept.
- The clinical management and outcome of nail salon-acquired Mycobacterium fortuitum skin infection.
- Epidemic and sporadic cases of nontuberculous mycobacterial keratitis associated with laser in situ keratomileusis.
- Exposure to rodents and rodent-borne viruses among persons with elevated occupational risk.
- An outbreak of mycobacterial furunculosis associated with footbaths at a nail salon.
- "Serious skin & soft tissue infections in rheumatoid arthritis patients taking anti-tumor necrosis factor alpha drugs: a nested case-control study".
- Risk of Herpes Zoster in Auto-immune and Inflammatory diseases: Implications for Vaccination.
Schools
Oregon Health Sciences University
Doctors Specialties
- Internal Medicine
- Infectious Disease
Accepted Insurances
Awards
- CMS Meaningful Use Stage 1 Certification
Education
-
Oregon Health & Science University School of Medicine
Drug Facts
| NPI NUMBER | 1679509525 | |
| NPPES Provider LastName | WINTHROP | |
| NPPES Provider FirstName | KEVIN | |
| NPPES Provider ZIPCode | 972394146 | |
| NPPES Provider State | OR | |
| Specialty Description | Infectious Disease | |
| Total Claim Count | 696.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1679509525 |
| Last Name Of The Provider | WINTHROP |
| First Name Of The Provider | KEVIN |
| View All |
Similar Doctors
|
Dr. Mark A. Crislip, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Lisa M. Lemond, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Amy Wang, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Lauren E. Kaplan, DO |
|
|
Dr. Susanne Shokoohi, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Mary M. Lindquist, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Amy D. Carolan, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Narain K. Kumar, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. James E. Leggett Jr., MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Michael S. MacVeigh, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Mark O. Loveless, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Nancy J. Macneal, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Andrew T. Root, MD
This Doctor is OpenDoctor Recommended.
|